
|Articles|October 31, 2001
The Case for Lipid Control
Reducing the amount of fat in the blood is the key weapon against heart disease, and the battle plan recently changed.
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Medicare Advantage enrollees more likely to leave after new complex diagnosis
2
FDA approves Gilead’s Bixlenvo, smallest single-tablet option for virologically suppressed HIV patients
3
FDA approves brepocitinib for rare skin disease
4
Real-World Safety Experience and Clinical Takeaways from the BE BOLD Trial
5





















